BioSpace News Archive

ASLAN Pharmaceuticals today announced the presentation of new eblasakimab and farudodstat data in late-breaker oral and poster presentations respectively, at the 1st International Societies for Investigative Dermatology (ISID) meeting, which took place from May 10 to 13, 2023, in Tokyo, Japan.

Zimmer Biomet Holdings, Inc. today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the second quarter of 2023.

Element Biosciences, Inc. announced it is now leveraging a new Amazon Omics feature, Ready2Run workflows, to provide simple, powerful, and cost-effective analysis workflows.

LENSAR, Inc. today announced financial results for the quarter ended March 31, 2023 and provided an update on key operational initiatives.

Castle Biosciences, Inc. today announced that it has been selected as the winner of the “Best Use of Artificial Intelligence in Healthcare” award in the seventh annual MedTech Breakthrough Awards program for its innovative TissueCypher® Barrett’s Esophagus test.

Minerva Neurosciences, Inc. reported business updates and financial results for the first quarter ended March 31, 2023.

Benitec Biopharma Inc., a development-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary DNA-directed RNA interference platform, announced financial results for its Third Fiscal Quarter ended March 31, 2023.

Protara Therapeutics, Inc. (Nasdaq: TARA) today announced that patient dosing is now underway in its Phase 1b ADVANCED-1EXP expansion trial evaluating TARA-002, the Company’s investigational cell-based therapy, for the treatment of patients with high-grade non-muscle invasive bladder cancer (NMIBC) who have carcinoma in situ (CIS).

Cue Biopharma, Inc. (Nasdaq: CUE) announced today the presentation of a poster at the American Society of Clinical Oncology (ASCO) Annual Meeting, taking place June 2-6, 2023 in Chicago, IL.

STRATA Skin Sciences, Inc. announced it has entered into an exclusive, three-year agreement with Spectra Medical India Pvt Ltd., a distribution company representing medical laser and aesthetic equipment manufacturers, for the distribution of TheraClear®X, VTRAC®, and XTRAC® in India.